Reduction in CO Emission from Small Reciprocating Engine Operated with Wood Gasifier by Mixture LHV Changing Tekijä Hiroshi Enomoto, Ryo Nakagawa

Hae kokoteksti

Economic analysis of reciprocating engine generating with bio-syngas at predicted maximum power condition Tekijä Hiroshi Enomoto, Ryo Nakagawa, Ayako Yoshimichi

Hae kokoteksti

Standardized evaluation of diabetic retinopathy using artificial intelligence and its association with metabolic dysfunction-associated steatotic liver disease in Japan: A cross-se... Tekijä Koji Komatsu, Kei Sano, Kota Fukai, Ryo Nakagawa, Takashi Nakagawa, Masayuki Tatemichi, Tadashi Nakano

Hae kokoteksti

Associated factors of diabetic retinopathy by artificial intelligence evaluation of fundus images in Japan Tekijä Koji Komatsu, Kei Sano, Kota Fukai, Ryo Nakagawa, Takashi Nakagawa, Masayuki Tatemichi, Tadashi Nakano

Hae kokoteksti

The effects of addition of carbon dioxide and water vapor on the dynamic behavior of spherically expanding hydrogen/air premixed flames Tekijä Toshiyuki KATSUMI, Yasuhito YOSHIDA, Ryo NAKAGAWA, Shinya YAZAWA, Masashi KUMADA, Daisuke SATO, Thwe Thwe Aung, Nabiha CHAUMEIX, Satoshi KADOWAKI

Hae kokoteksti

Elevation of enterococcus-specific antibodies associated with bacterial translocation is predictive of survival rate in chronic liver disease Tekijä Motoh Iwasa, Akiko Eguchi, Yasuyuki Tamai, Ryuta Shigefuku, Ryo Nakagawa, Hiroshi Hasegawa, Jumpei Kondo, Masayuki Morikawa, Eiji Miyoshi, Hayato Nakagawa

Hae kokoteksti

BK Virus-Associated Urothelial Carcinoma in a Patient with Peripheral Blood Stem Cell Transplantation for Acute Lymphoblastic Leukemia: A Case Report Tekijä Juntaro Koyama, Yoshihide Kawasaki, Shingo Kimura, Takuma Sato, Shuichi Shimada, Naoki Kawamorita, Shinichi Yamashita, Ryo Nakagawa, Akihisa Kawajiri, Koichi Onodera, Yasushi Onishi, Koji Mitsuzuka, Mika Watanabe, Akihiro Ito

Hae kokoteksti

From Microwave Acoustic Filters to Millimeter-Wave Operation and New Applications Tekijä Amelie Hagelauer, Rich Ruby, Shogo Inoue, Victor Plessky, Ken-Ya Hashimoto, Ryo Nakagawa, Jordi Verdu, Pedro de Paco, Amir Mortazawi, Gianluca Piazza, Zachary Schaffer, Ernest Ting-Ta Yen, Thomas Forster, Andreas Tag

Hae kokoteksti

Baseline soluble MICA levels act as a predictive biomarker for the efficacy of regorafenib treatment in colorectal cancer Tekijä Jun Arai, Yumi Otoyama, Ken-ichi Fujita, Kaku Goto, Masayuki Tojo, Atsushi Katagiri, Hisako Nozawa, Yutaro Kubota, Takehiro Takahashi, Hiroo Ishida, Takuya Tsunoda, Natsumi Matsumoto, Keita Ogawa, Ryo Nakagawa, Ryosuke Muroyama, Naoya Kato, Hitoshi Yoshida

Hae kokoteksti

Combination of serum human satellite RNA and miR-21-5p levels as a biomarker for pancreatic cancer Tekijä Takahiro Seimiya, Tatsunori Suzuki, Takuma Iwata, Takahiro Kishikawa, Kazuma Sekiba, Chikako Shibata, Kazunaga Ishigaki, Hiroaki Fujiwara, Hiroki Oyama, Sachiko Kanai, Tatsuya Sato, Yousuke Nakai, Rei Ishibashi, Masaru Moriyama, Ryo Nakagawa, Hideaki Ijichi, Motoyuki Otsuka, Kazuhiko Koike

Hae kokoteksti

Induction of aggressive arterial and venous dilation therapy in addition to pulmonary dilation therapy (super-Fontan strategy) improves Fontan circulation both at rest and during t... Tekijä Shoichi Ishikawa, MD, Shun Matsumura, MD, PhD, Akiko Yana, MD, Clara Kurishima, MD, Yoichi Iwamoto, MD, PhD, Hirotaka Ishido, MD, PhD, Satoshi Masutani, MD, PhD, FAHA, Ryo Nakagawa, MD, PhD, Hideaki Senzaki, MD, PhD, FAHA

Hae kokoteksti

Investigation of risk factors for metachronous recurrence in patients with early gastric adenocarcinoma by miRNA–mRNA integral profiling Tekijä Ariki Nagashima, Kenichiro Okimoto, Ryo Nakagawa, Naoki Akizue, Tomoaki Matsumura, Hirotaka Oura, Ryuta Kojima, Chihiro Goto, Satsuki Takahashi, Ryosuke Horio, Akane Kurosugi, Tsubasa Ishikawa, Wataru Shiratori, Tatsuya Kaneko, Kengo Kanayama, Yuki Ohta, Takashi Taida, Keiko Saito, Tetsuhiro Chiba, Jun Kato, Naoya Kato

Hae kokoteksti

Cabozantinib for Advanced Hepatocellular Carcinoma in the Latest Real-World Practice: A Multicenter Retrospective Analysis Tekijä Hiroaki Kanzaki, Sadahisa Ogasawara, Tomomi Okubo, Norio Itokawa, Ryohei Yoshino, Kentaro Fujimoto, Tadayoshi Kogure, Sae Yumita, Takamasa Ishino, Keita Ogawa, Terunao Iwanaga, Miyuki Nakagawa, Kisako Fujiwara, Ryuta Kojima, Keisuke Koroki, Masanori Inoue, Kazufumi Kobayashi, Naoya Kanogawa, Soichiro Kiyono, Masato Nakamura, Takayuki Kondo, Ryo Nakagawa, Shingo Nakamoto, Ryosuke Muroyama, Ei Itobayashi, Masanori Atsukawa, Jun Kato, Naoya Kato

Hae kokoteksti

Durvalumab with or without tremelimumab combined with particle therapy for advanced hepatocellular carcinoma with macrovascular invasion: protocol for the DEPARTURE phase Ib trial Tekijä Masato Nakamura, Takayuki Kondo, Yohei Kawasaki, Hideki Hanaoka, Naoya Kato, Sadahisa Ogasawara, Keisuke Koroki, Hirokazu Makishima, Masaru Wakatsuki, Asahi Takahashi, Sae Yumita, Miyuki Nakagawa, Takamasa Ishino, Keita Ogawa, Kisako Fujiwara, Terunao Iwanaga, Takafumi Sakuma, Naoto Fujita, Ryuta Kojima, Hiroaki Kanzaki, Kazufumi Kobayashi, Soichiro Kiyono, Naoya Kanogawa, Tomoko Saito, Ryo Nakagawa, Shingo Nakamoto, Ryosuke Muroyama, Tetsuhiro Chiba, Yoshihito Ozawa, Tomoya Kurokawa, Hiroshi Tsuji

Hae kokoteksti

The impact of FGF19/FGFR4 signaling inhibition in antitumor activity of multi-kinase inhibitors in hepatocellular carcinoma Tekijä Hiroaki Kanzaki, Tetsuhiro Chiba, Junjie Ao, Keisuke Koroki, Kengo Kanayama, Susumu Maruta, Takahiro Maeda, Yuko Kusakabe, Kazufumi Kobayashi, Naoya Kanogawa, Soichiro Kiyono, Masato Nakamura, Takayuki Kondo, Tomoko Saito, Ryo Nakagawa, Sadahisa Ogasawara, Eiichiro Suzuki, Yoshihiko Ooka, Ryosuke Muroyama, Shingo Nakamoto, Shin Yasui, Akinobu Tawada, Makoto Arai, Tatsuo Kanda, Hitoshi Maruyama, Naoya Mimura, Jun Kato, Yoh Zen, Masayuki Ohtsuka, Atsushi Iwama, Naoya Kato

Hae kokoteksti

Controlling Major Portal Vein Invasion Progression during Lenvatinib Treatment by Carbon-Ion Radiotherapy in Patients with Advanced Hepatocellular Carcinoma Tekijä Ryoi Yoshida, Keisuke Koroki, Hirokazu Makishima, Sadahisa Ogasawara, Takamasa Ishino, Keita Ogawa, Miyuki Nakagawa, Kisako Fujiwara, Hidemi Unozawa, Terunao Iwanaga, Naoto Fujita, Takafumi Sakuma, Hiroaki Kanzaki, Kazufumi Kobayashi, Naoya Kanogawa, Soichiro Kiyono, Masato Nakamura, Takayuki Kondo, Tomoko Saito, Ryo Nakagawa, Eiichiro Suzuki, Yoshihiko Ooka, Shingo Nakamoto, Akinobu Tawada, Tetsuhiro Chiba, Makoto Arai, Takashi Kaneko, Masaru Wakatsuki, Jun Kato, Hiroshi Tsuji, Naoya Kato

Hae kokoteksti

EZH1/2 inhibition augments the anti-tumor effects of sorafenib in hepatocellular carcinoma Tekijä Yuko Kusakabe, Tetsuhiro Chiba, Motohiko Oshima, Shuhei Koide, Ola Rizq, Kazumasa Aoyama, Junjie Ao, Tatsuya Kaneko, Hiroaki Kanzaki, Kengo Kanayama, Takahiro Maeda, Tomoko Saito, Ryo Nakagawa, Kazufumi Kobayashi, Soichiro Kiyono, Masato Nakamura, Sadahisa Ogasawara, Eiichiro Suzuki, Shingo Nakamoto, Shin Yasui, Rintaro Mikata, Ryosuke Muroyama, Tatsuo Kanda, Hitoshi Maruyama, Jun Kato, Naoya Mimura, Anqi Ma, Jian Jin, Yoh Zen, Masayuki Otsuka, Atsushi Kaneda, Atsushi Iwama, Naoya Kato

Hae kokoteksti

Use of ramucirumab for various treatment lines in real-world practice of patients with advanced hepatocellular carcinoma Tekijä Naoya Kanogawa, Sadahisa Ogasawara, Susumu Maruta, Yotaro Iino, Masamichi Obu, Takamasa Ishino, Keita Ogawa, Sae Yumita, Terunao Iwanaga, Hidemi Unozawa, Miyuki Nakagawa, Kisako Fujiwara, Takafumi Sakuma, Naoto Fujita, Ryuta Kojima, Hiroaki Kanzaki, Keisuke Koroki, Kazufumi Kobayashi, Masanori Inoue, Soichiro Kiyono, Masato Nakamura, Takayuki Kondo, Tomoko Saito, Ryo Nakagawa, Shingo Nakamoto, Ryosuke Muroyama, Tetsuhiro Chiba, Ei Itobayashi, Yoshihiro Koma, Ryosaku Azemoto, Jun Kato, Naoya Kato

Hae kokoteksti

Evolution of Survival Impact of Molecular Target Agents in Patients with Advanced Hepatocellular Carcinoma Tekijä Kazufumi Kobayashi, Sadahisa Ogasawara, Aya Takahashi, Yuya Seko, Hidemi Unozawa, Rui Sato, Shunji Watanabe, Michihisa Moriguchi, Naoki Morimoto, Satoshi Tsuchiya, Kenji Iwai, Masanori Inoue, Keita Ogawa, Takamasa Ishino, Terunao Iwanaga, Takafumi Sakuma, Naoto Fujita, Hiroaki Kanzaki, Keisuke Koroki, Masato Nakamura, Naoya Kanogawa, Soichiro Kiyono, Takayuki Kondo, Tomoko Saito, Ryo Nakagawa, Eiichiro Suzuki, Yoshihiko Ooka, Shingo Nakamoto, Akinobu Tawada, Tetsuhiro Chiba, Makoto Arai, Tatsuo Kanda, Hitoshi Maruyama, Kengo Nagashima, Jun Kato, Norio Isoda, Takeshi Aramaki, Yoshito Itoh, Naoya Kato

Hae kokoteksti

Hyperprogressive disease during atezolizumab plus bevacizumab treatment in patients with advanced hepatocellular carcinoma from Japanese real-world practice Tekijä Sae Yumita, Sadahisa Ogasawara, Miyuki Nakagawa, Susumu Maruta, Tomomi Okubo, Norio Itokawa, Yotaro Iino, Masamichi Obu, Yuki Haga, Atsuyoshi Seki, Tadayoshi Kogure, Takamasa Ishino, Keita Ogawa, Kisako Fujiwara, Terunao Iwanaga, Naoto Fujita, Takafumi Sakuma, Ryuta Kojima, Hiroaki Kanzaki, Keisuke Koroki, Masanori Inoue, Kazufumi Kobayashi, Soichiro Kiyono, Masato Nakamura, Naoya Kanogawa, Tomoko Saito, Takayuki Kondo, Ryo Nakagawa, Shingo Nakamoto, Ryosuke Muroyama, Tetsuhiro Chiba, Ei Itobayashi, Masanori Atsukawa, Yoshihiro Koma, Ryosaku Azemoto, Kenji Ito, Hideaki Mizumoto, Jun Kato, Naoya Kato

Hae kokoteksti